Key result
Emergency splenectomy and adjuvant chemotherapy achieved 18 months of recurrence-free survival in a 42-year-old man presenting with a ruptured primary splenic angiosarcoma.
Population
42-year-old man with spontaneously ruptured primary splenic angiosarcoma presenting with sudden abdominal pain
Design
Case_report
Follow-up
18 months
Authors
Loading...
Supports splenectomy plus chemotherapy in ruptured splenic angiosarcoma; hypothesis-generating and should not yet change practice.
Splenectomy followed by adjuvant chemotherapy with epirubicin and ifosfamide may provide long-term recurrence-free survival in patients with spontaneously ruptured splenic angiosarcoma.
Yamamoto et al. (2014) studied this question. Emergency splenectomy and adjuvant chemotherapy achieved 18 months of recurrence-free survival in a 42-year-old man presenting with a ruptured primary splenic angiosarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: